In Vitro Activity of Sulbactam–Durlobactam against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: A Multicentre Report from Italy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vitro Activity of Sulbactam–Durlobactam against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: A Multicentre Report from Italy
Authors
Keywords
-
Journal
Antibiotics-Basel
Volume 11, Issue 8, Pages 1136
Publisher
MDPI AG
Online
2022-08-23
DOI
10.3390/antibiotics11081136
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates From Greece
- (2022) Dimitra Petropoulou et al. Frontiers in Cellular and Infection Microbiology
- Resistome and Virulome of Multi-Drug Resistant E. coli ST131 Isolated from Residents of Long-Term Care Facilities in the Northern Italian Region
- (2022) Sabrina Cherubini et al. Diagnostics
- Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options
- (2022) Carmi Bartal et al. Infectious Diseases and Therapy
- Risk of community- and hospital-acquired bacteremia and profile of antibiotic resistance in children hospitalized with severe acute malnutrition in Niger
- (2022) Christopher T. Andersen et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- In-vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance
- (2022) Jacqueline Findlay et al. Journal of Global Antimicrobial Resistance
- Durlobactam in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infections: A Systematic Review
- (2022) Guido Granata et al. Journal of Clinical Medicine
- Whole-Genome Sequencing of ST2 A. baumannii Causing Bloodstream Infections in COVID-19 Patients
- (2022) Sabrina Cherubini et al. Antibiotics-Basel
- In vitro activity of sulbactam-durlobactam against extensive-drug-resistant Acinetobacter baumannii isolates belonging to South America major clones
- (2021) Carolina S. Nodari et al. Journal of Global Antimicrobial Resistance
- Acinetobacter baumannii Antibiotic Resistance Mechanisms
- (2021) Ioannis Kyriakidis et al. Pathogens
- Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit
- (2021) Alessandro Russo et al. INFECTION
- Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam
- (2021) Adam B. Shapiro et al. Frontiers in Microbiology
- Whole-Genome Sequencing (WGS) of Carbapenem-Resistant K. pneumoniae Isolated in Long-Term Care Facilities in the Northern Italian Region
- (2021) Alessandra Piccirilli et al. Microorganisms
- Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update
- (2021) Emily N. Drwiega et al. CLINICAL PHARMACOKINETICS
- Bacterial Antibiotic Resistance: The Most Critical Pathogens
- (2021) Giuseppe Mancuso et al. Pathogens
- In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples
- (2021) Davide Carcione et al. Antibiotics-Basel
- In vitro activity of sulbactam-durlobactam against Acinetobacter baumannii-calcoaceticus complex isolates collected globally from 2016-2017
- (2020) Sarah M. McLeod et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multi-drug resistant bacteria predict mortality in bloodstream infection in a tertiary setting in Tanzania
- (2020) Joel Manyahi et al. PLoS One
- In vitro activity of sulbactam/durlobactam against clinical isolates of Acinetobacter baumannii collected in China
- (2020) Qiwen Yang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace
- (2020) Maria Soledad Ramirez et al. Biomolecules
- Phenotypic and WGS-derived antimicrobial resistance profiles of clinical and non-clinical Acinetobacter baumannii isolates from Germany and Vietnam
- (2020) Gamal Wareth et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii
- (2020) Harald Seifert et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ventilator-associated Pneumonia: Multidrug Resistant Acinetobacter vs. Extended Spectrum Beta Lactamase-producing Klebsiella
- (2020) Mohammadreza Salehi et al. Journal of Infection in Developing Countries
- Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii
- (2020) Corneliu Ovidiu Vrancianu et al. Microorganisms
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Efficacy of a Fosfomycin-Containing Regimen for Treatment of Severe Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii: A Prospective, Observational Study
- (2020) Alessandro Russo et al. Infectious Diseases and Therapy
- Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Isolates Belonging to Major Endemic Clones in South America
- (2020) Carolina Silva Nodari et al. Frontiers in Microbiology
- Interactions of the Diazabicyclooctane Serine β-Lactamase Inhibitor ETX1317 with Target Enzymes
- (2020) Adam B. Shapiro et al. ACS Infectious Diseases
- Acinetobacter spp. in food and drinking water – A review
- (2020) Ana Carvalheira et al. FOOD MICROBIOLOGY
- Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent
- (2019) Melissa D. Barnes et al. mBio
- Carbapenem-resistant Acinetobacterbaumannii: in pursuitof an effective treatment
- (2019) Evangelia-Theophano Piperaki et al. CLINICAL MICROBIOLOGY AND INFECTION
- Global prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: A systematic review and meta-analysis
- (2019) Ali Pormohammad et al. MICROBIAL PATHOGENESIS
- Functional characterization of AbaQ, a novel efflux pump mediating quinolone resistance in Acinetobacter baumannii.
- (2018) María Pérez-Varela et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects
- (2018) Keith A. Rodvold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities
- (2018) Muhammad Asif et al. Infection and Drug Resistance
- In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)
- (2018) Krystyna M. Kazmierczak et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Development and evaluation of a core genome multilocus typing scheme for whole-genome sequence-based typing of Acinetobacter baumannii
- (2017) Paul G. Higgins et al. PLoS One
- Antibiotic Resistance of Acinetobacter spp. Isolates from the River Danube: Susceptibility Stays High
- (2017) Clemens Kittinger et al. International Journal of Environmental Research and Public Health
- Reversibility of Covalent, Broad-Spectrum Serine β-Lactamase Inhibition by the Diazabicyclooctenone ETX2514
- (2017) Adam B. Shapiro et al. ACS Infectious Diseases
- ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii
- (2017) Thomas F. Durand-Réville et al. Nature Microbiology
- Molecular Mechanisms of Sulbactam Antibacterial Activity and Resistance Determinants in Acinetobacter baumannii
- (2015) William F. Penwell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: Considerations on in vitro assay of active drugs
- (2014) Maria Lina Mezzatesta et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Epidemic Diffusion of OXA-23-Producing Acinetobacter baumannii Isolates in Italy: Results of the First Cross-Sectional Countrywide Survey
- (2014) L. Principe et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Carbapenem resistance and acquired class D beta-lactamases in Acinetobacter baumannii from Croatia 2009–2010
- (2013) M. Vranić-Ladavac et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Characterization of resistance mechanisms and genetic relatedness of carbapenem-resistant Acinetobacter baumannii isolated from blood, Italy
- (2012) Roberta Migliavacca et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy
- (2011) M.L. Mezzatesta et al. CLINICAL MICROBIOLOGY AND INFECTION
- Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy
- (2010) Silvia D'Arezzo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Role of AbeS, a Novel Efflux Pump of the SMR Family of Transporters, in Resistance to Antimicrobial Agents in Acinetobacter baumannii
- (2009) V. B. Srinivasan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii
- (2009) Elisabetta Nucleo et al. BMC MICROBIOLOGY
- Whole-Genome Pyrosequencing of an Epidemic Multidrug-Resistant Acinetobacter baumannii Strain Belonging to the European Clone II Group
- (2008) M. Iacono et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started